HealthLeaders Media August 2, 2018
Steven Porter

California formally urged the DOJ to block one blockbuster PBM deal, and a powerful investor came out against the other.

Two planned mergers involving some of the largest pharmacy benefit managers in the country hit separate snags Wednesday that could derail the potentially industry-shifting proposals.

California Insurance Commissioner Dave Jones formally urged the U.S. Department of Justice to block CVS Health’s planned $69 billion purchase of Aetna on anti-competitive grounds, and news broke that activist investor Carl Icahn plans to vote against Cigna’s planned $54 billion purchase of Express Scripts.

The two separate developments threw cold water on the closely watched deals, which observers had said could dramatically change the healthcare industry.

CALIFORNIA’S CONCERNS

Although the verticality of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Provider, Retail care, Trends
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Novant Health and CHS counter FTC bid to block hospital deal
Informatica says it's not for sale, following Salesforce's reported interest in $10 billion deal
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
CHS to sell Tennessee hospital for $160M

Share This Article